University of Minnesota
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
NCT Number: NCT07433712
This trial will assess the feasibility, acceptability, and preliminary effectiveness of Project REACH (Remote Engagement & Access for Community Health), a telehealth intervention at syringe service programs (SSP) to improve access to HIV-related evidence-based interventions (EBI) for people who use drugs including those who inject them.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
People Who Use Drugs Inclusion Criteria:
People Who Use Drugs Exclusion Criteria:
Stakeholder Inclusion Criteria:
Stakeholder Exclusion Criteria:
The primary interactions with participants of Project REACH will consist of SSP-based recruitment and enrollment, provision of telehealth services at SSPs for the 6-month pilot duration, and exit interviews with a subset of participants and SSP study staff following the trial.
Time frame: Year 2
Proportion of enrolled participants who complete the study
Time frame: Year 2
Assessed in exit interviews
Time frame: Year 2
EPIC Smartforms
Time frame: Year 2
EPIC Smartforms
Contact information is provided by the study sponsor or research team.
University of Minnesota
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05933226
Acquired Immunodeficiency Syndrome, Alcohol Drinking
Cape Town, Western Cape, South Africa
View Trial DetailsNCT04595084
Alcohol Drinking, Alcohol Use, Unspecified
Cambridge, Massachusetts, United States
View Trial DetailsNCT05736211
Chemically-Induced Disorders, Drug Use
Winston-Salem, North Carolina, United States
View Trial DetailsNCT04544124
Adults, Chemically-Induced Disorders
Calgary, Alberta, Canada
View Trial Details